Skip to content

Clinical trials

Withdrawn Lymphoma, B-Cell, Marginal Zone trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Status: Withdrawn Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20072
20081
20102
20143
20153
20161
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoag Memorial Hospital Presbyterian2
Masonic Cancer Center, University of Minnesota2
National Cancer Institute (NCI)2
Academic and Community Cancer Research United1
Alliance for Clinical Trials in Oncology1
CTI BioPharma1
Fred Hutchinson Cancer Center1
Hutchmed1
Louisiana State University Health Sciences Center Shreveport1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone20
Lymphoma, Follicular19
Leukemia, Lymphocytic, Chronic, B-Cell18
Lymphoma, Mantle-Cell15
Lymphoma, Large B-Cell, Diffuse11
Lymphoma, Non-Hodgkin11
Lymphoma10
Burkitt Lymphoma9
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Waldenstrom Macroglobulinemia9

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.